204 related articles for article (PubMed ID: 10697315)
1. Experience in the treatment of dedifferentiated chondrosarcoma.
Mitchell AD; Ayoub K; Mangham DC; Grimer RJ; Carter SR; Tillman RM
J Bone Joint Surg Br; 2000 Jan; 82(1):55-61. PubMed ID: 10697315
[TBL] [Abstract][Full Text] [Related]
2. Chondrosarcoma of bone: an assessment of outcome.
Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.
Dickey ID; Rose PS; Fuchs B; Wold LE; Okuno SH; Sim FH; Scully SP
J Bone Joint Surg Am; 2004 Nov; 86(11):2412-8. PubMed ID: 15523011
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute.
Bertoni F; Bacchini P; Staals EL; Davidovitz P
Cancer; 2005 Jun; 103(11):2373-82. PubMed ID: 15852358
[TBL] [Abstract][Full Text] [Related]
5. [Cartilage tumours of the bone. Diagnosis and therapy].
Streitbuerger A; Hardes J; Gebert C; Ahrens H; Winkelmann W; Gosheger G
Orthopade; 2006 Aug; 35(8):871-81; quiz 882. PubMed ID: 16865383
[TBL] [Abstract][Full Text] [Related]
6. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
7. Conventional Primary Central Chondrosarcoma of the Pelvis: Prognostic Factors and Outcome of Surgical Treatment in 162 Patients.
Bus MPA; Campanacci DA; Albergo JI; Leithner A; van de Sande MAJ; Gaston CL; Caff G; Mettelsiefen J; Capanna R; Tunn PU; Jeys LM; Dijkstra PDS
J Bone Joint Surg Am; 2018 Feb; 100(4):316-325. PubMed ID: 29462035
[TBL] [Abstract][Full Text] [Related]
8. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
[TBL] [Abstract][Full Text] [Related]
9. Outcome of pathologic fractures of the proximal femur in nonosteogenic primary bone sarcoma.
Chandrasekar CR; Grimer RJ; Carter SR; Tillman RM; Abudu AT; Jeys LM
Eur J Surg Oncol; 2011 Jun; 37(6):532-6. PubMed ID: 21377313
[TBL] [Abstract][Full Text] [Related]
10. Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?
Thio QCBS; Karhade AV; Ogink PT; Raskin KA; De Amorim Bernstein K; Lozano Calderon SA; Schwab JH
Clin Orthop Relat Res; 2018 Oct; 476(10):2040-2048. PubMed ID: 30179954
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated central chondrosarcoma.
Staals EL; Bacchini P; Bertoni F
Cancer; 2006 Jun; 106(12):2682-91. PubMed ID: 16691621
[TBL] [Abstract][Full Text] [Related]
12. Low Grade Chondrosarcoma - Epidemiology, Diagnosis, Treatment.
Karpik M; Reszeć J
Ortop Traumatol Rehabil; 2018 Feb; 20(1):65-70. PubMed ID: 30152763
[TBL] [Abstract][Full Text] [Related]
13. Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
Hompland I; Ferrari S; Bielack S; Palmerini E; Hall KS; Picci P; Hecker-Nolting S; Donati DM; Blattmann C; Bjerkehagen B; Staals E; Kager L; Gambarotti M; Kühne T; Eriksson M; Ferraresi V; Kevric M; Biagini R; Baumhoer D; Brosjø O; Comandone A; Schwarz R; Bertulli R; Kessler T; Hansson L; Apice G; Heydrich BN; Setola E; Flörcken A; Ruggieri P; Krasniqi F; Hofmann-Wackersreuther G; Casali P; Reichardt P; Smeland S
Eur J Cancer; 2021 Jul; 151():150-158. PubMed ID: 33990016
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated chondrosarcoma.
Mercuri M; Picci P; Campanacci L; Rulli E
Skeletal Radiol; 1995 Aug; 24(6):409-16. PubMed ID: 7481896
[TBL] [Abstract][Full Text] [Related]
15. Chondrosarcoma of bone.
Leddy LR; Holmes RE
Cancer Treat Res; 2014; 162():117-30. PubMed ID: 25070233
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of mesenchymal chondrosarcoma].
Murav'ev GN; Fradkin SZ; Zhavrid EA; Furmanchuk AV; Bogovich IuA; Frolov GN
Vopr Onkol; 1989; 35(10):1170-5. PubMed ID: 2596059
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated chondrosarcoma: current standards of care.
Kattepur AK; Jones RL; Gulia A
Future Oncol; 2021 Dec; 17(35):4983-4991. PubMed ID: 34734747
[TBL] [Abstract][Full Text] [Related]
18. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome for patients with dedifferentiated chondrosarcoma: a report of 9 cases at a single institute.
Yokota K; Sakamoto A; Matsumoto Y; Matsuda S; Harimaya K; Oda Y; Iwamoto Y
J Orthop Surg Res; 2012 Dec; 7():38. PubMed ID: 23227977
[TBL] [Abstract][Full Text] [Related]
20. The presentation, treatment and outcome of periosteal chondrosarcoma in the Netherlands.
Goedhart LM; Ploegmakers JJ; Kroon HM; Zwartkruis EC; Jutte PC
Bone Joint J; 2014 Jun; 96-B(6):823-8. PubMed ID: 24891585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
